Estimación de la prevalencia, incidencia, comorbilidades y costes directos asociados en pacientes que demandan atención por ictus en un ámbito poblacional español

J, Fernández de Bobadilla; Sicras‐Mainar, Antoni; Navarro‐Artieda, Ruth; Planas-Comes, Albert; Soto-Álvarez, J.; Sánchez-Maestre, C; C, Alvarez-Martín; D, Ezpeleta-Echevarri

doi:10.33588/rn.4607.2008052

Cited by 12 publications

(12 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our society, aging of the population is increasing the absolute incidence of stroke and other diseases that generate dependence, which has raised the need for a new epidemiological approach to their management. More recently, this has been joined by the social and public health perspective owing to the high economic and social impact of these diseases, which generate a large demand for medical care in both the PC and specialized care setting 1–3 . Similarly, although the progress made in hospital care has improved life expectancy, the approach to treatment of stroke following hospitalization is not as active as it could be when compared with coronary heart disease 16,17 .…”

Section: Discussionmentioning

confidence: 99%

“…More recently, this has been joined by the social and public health perspective owing to the high economic and social impact of these diseases, which generate a large demand for medical care in both the PC and specialized care setting. [1][2][3] Similarly, although the progress made in hospital care has improved life expectancy, the approach to treatment of stroke following hospitalization is not as active as it could be when compared with coronary heart disease. 16,17 Prevention strategies are essential not only to reduce the incidence of primary stroke, but, with greater emphasis, that of recurrent stroke and other cardiovascular events.…”

Section: Discussionmentioning

confidence: 99%

“…Stroke is a major cause of morbidity, mortality and disability in developed countries, with a high economic and social cost and generates a large demand in both primary care (PC) and specialized care centres 1–3 . Its life‐time prevalence ranges from 2% to 10% of the adult population, although it varies according to the different countries and settings and is mostly related to genetic and environmental factors and cardiovascular risk factors (CVRF).…”

Section: What Is Known and Objectivementioning

confidence: 99%

“…Its life‐time prevalence ranges from 2% to 10% of the adult population, although it varies according to the different countries and settings and is mostly related to genetic and environmental factors and cardiovascular risk factors (CVRF). Therefore, measures aimed at stroke prevention and CVRF identification and control are the primary strategies to reduce its impact on public health 3,4 …”

Section: What Is Known and Objectivementioning

confidence: 99%

“…Therefore, measures aimed at stroke prevention and CVRF identification and control are the primary strategies to reduce its impact on public health. 3,4 It is estimated that the stroke recurrence rate is 12% in the first year and 30% at 5 years, with an increased risk of atherothrombotic strokes. 5,6 Furthermore, there is a 15% risk of myocardial infarction and cardiovascular death in individuals who have had a previous stroke, and it has been shown that mortality from a cardiac cause is double that caused by stroke.…”

Section: What Is Known and Objectivementioning

confidence: 99%

See 4 more Smart Citations

Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease

Sicras‐Mainar¹,

Planas-Comes²,

Frias-Garrido³

et al. 2011

Journal of Clinical Pharmacy and Therapeutics

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: What Is Known and Objectivementioning

confidence: 99%

Section: What Is Known and Objectivementioning

confidence: 99%

Section: What Is Known and Objectivementioning

confidence: 99%

See 3 more Smart Citations

Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease

Sicras‐Mainar¹,

Planas-Comes²,

Frias-Garrido³

et al. 2011

Journal of Clinical Pharmacy and Therapeutics

View full text Add to dashboard Cite

show abstract

The global impact of non-communicable diseases on healthcare spending and national income: a systematic review

et al. 2015

View full text Add to dashboard Cite

The impact of non-communicable diseases (NCDs) in populations extends beyond ill-health and mortality with large financial consequences. To systematically review and meta-analyze studies evaluating the impact of NCDs (including coronary heart disease, stroke, type 2 diabetes mellitus, cancer (lung, colon, cervical and breast), chronic obstructive pulmonary disease and chronic kidney disease) at the macro-economic level: healthcare spending and national income. Medical databases (Medline, Embase and Google Scholar) up to November 6th 2014. For further identification of suitable studies, we searched reference lists of included studies and contacted experts in the field. We included randomized controlled trials, systematic reviews, cohorts, case-control, cross-sectional, modeling and ecological studies carried out in adults assessing the economic consequences of NCDs on healthcare spending and national income without language restrictions. All abstracts and full text selection was done by two independent reviewers. Any disagreements were resolved through consensus or consultation of a third reviewer. Data were extracted by two independent reviewers using a pre-designed data collection form. Studies evaluating the impact of at least one of the selected NCDs on at least one of the following outcome measures: healthcare expenditure, national income, hospital spending, gross domestic product (GDP), gross national product, net national income, adjusted national income, total costs, direct costs, indirect costs, inpatient costs, outpatient costs, per capita healthcare spending, aggregate economic outcome, capital loss in production levels in a country, economic growth, GDP per capita (per capita income), percentage change in GDP, intensive growth, extensive growth, employment, direct governmental expenditure and non-governmental expenditure. From 4,364 references, 153 studies met our inclusion criteria. Most of the studies were focused on healthcare related costs of NCDs. 30 studies reported the economic impact of NCDs on healthcare budgets and 13 on national income. Healthcare expenditure for cardiovascular disease (12-16.5 %) was the highest; other NCDs ranged between 0.7 and 7.4 %. NCD-related health costs vary across the countries, regions, and according to type of NCD. Additionally, there is an increase in costs with increased severity and years lived with the disease. Low- and middle-income (LMI) countries were the focus of just 16 papers, which suggests an information shortage concerning the true economic burden of NCDs in these countries. NCDs pose a significant financial burden on healthcare budgets and nations' welfare, which is likely to increase over time. However further work is required to standardize more consistently the methods available to assess the economic impact of NCDs and to involve (hitherto under-addressed) LMI populations across the globe.

show abstract

Presencia de puntos gatillo miofasciales en pacientes con ictus isquémico agudo: estudio piloto descriptivo transversal

et al. 2019

View full text Add to dashboard Cite

Estimación de la prevalencia, incidencia, comorbilidades y costes directos asociados en pacientes que demandan atención por ictus en un ámbito poblacional español

Cited by 12 publications

References 0 publications

Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease

Statins after recent stroke reduces recurrence and improves survival in an aging Mediterranean population without known coronary heart disease

The global impact of non-communicable diseases on healthcare spending and national income: a systematic review

Presencia de puntos gatillo miofasciales en pacientes con ictus isquémico agudo: estudio piloto descriptivo transversal

Contact Info

Product

Resources

About